Finance

Lists
HCA:NYSE
HCA Healthcare Inc
470,44 $
0,00%
(0,00) 1D
14 қаз., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HCA...
Mkt. cap
101,85 млрд
Avg. vol.
1,37 млн
Volume
670,00
Dividend
0,66%
Quarterly dividend
0,78 $
Ex-dividend date
2026 ж. 16 қыр.
P/E ratio
15,75
52-wk high
556,52 $
52-wk low
353,99 $
EPS
29,87 $
Beta
1,11
Shares outstanding
216,50 млн
No. of employees
275 м.
Mkt. cap
101,85 млрд
Avg. vol.
1,37 млн
Volume
670,00
Dividend
0,66%
Quarterly dividend
0,78 $
Ex-dividend date
2026 ж. 16 қыр.
P/E ratio
15,75
52-wk high
556,52 $
52-wk low
353,99 $
EPS
29,87 $
Beta
1,11
Shares outstanding
216,50 млн
No. of employees
275 м.
News stories
From web sources and news partners
Profile
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors. Wikipedia
About HCA Healthcare Inc
CEOSamuel N. Hazen
Employees275 м.
Founded1968
HeadquartersНашвилл, Теннесси, Америка Құрама Штаттары
SectorHealth care provider
Websitehcahealthcare.com
Analyst ratings
Based on 21 analysts giving stock ratings to HCA in the past 3 months
Buy
Buy
13
Hold
7
Sell
1
12-month forecast
Based on 21 Wall Street analysts offering 12 month price targets for HCA in the last 3 months.
Highest
Current 470,44 $
579,00 $ (+23,08%)
Average
455,16 $ (-3,25%)
Lowest
380,00 $ (-19,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
460,00 $
-2,2%
10/12/2026
Ben Hendrix
RBC Capital
Buy
Maintained
496,00 $
+5,4%
10/07/2026
Andrew Mok CFA
Barclays
Hold
Maintained
387,00 $
-17,7%
10/07/2026
Lance Wilkes
Bernstein
Hold
Maintained
426,00 $
-9,4%
10/05/2026
Andrew Cooper
Raymond James
Hold
Reiterated
-
-
09/28/2026
Sean Dodge
BMO Capital
Buy
Initiated
495,00 $
+5,2%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
450,00 $
-4,3%
09/17/2026
Benjamin Rossi
J.P. Morgan
Hold
Maintained
425,00 $
-9,7%
08/24/2026
Kevin Fischbeck
Bank of America Securities
Hold
Reiterated
425,00 $
-9,7%
08/10/2026
Unknown Analyst
Argus Research
Buy
Maintained
500,00 $
+6,3%
08/07/2026
David Toung
Argus Research
Buy
Reiterated
500,00 $
+6,3%
08/07/2026
David S Macdonald
Truist Financial
Buy
Reiterated
495,00 $
+5,2%
08/05/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
381,00 $
-19%
08/03/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
475,00 $
+1%
07/28/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
485,00 $
+3,1%
07/27/2026
A.J. Rice
UBS
Buy
Maintained
579,00 $
+23,1%
07/27/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
476,00 $
+1,2%
07/27/2026
Craig Hettenbach
Morgan Stanley
Sell
Maintained
380,00 $
-19,2%
07/27/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
485,00 $
+3,1%
07/27/2026
Michael Ha
Robert W. Baird
Hold
Maintained
393,00 $
-16,5%
07/27/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
435,00 $
-7,5%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
525,00 $
+11,6%
07/14/2026
Unknown Analyst
Stephens
Buy
Reiterated
530,00 $
+12,7%
04/27/2026
Raj Kumar CFA
Stephens
Buy
Reiterated
530,00 $
+12,7%
04/27/2026
Courtney Breen
Bernstein
Hold
Maintained
541,00 $
+15%
03/30/2026
Next call 12 күннен кейін
27 қаз., сс, 16:00
Fiscal period
Q3 2026
- / 6,65 $
Revenue / Est. (USD)
- / 19,33 млрд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
19,16 млрд
19,51 млрд
19,11 млрд
20,23 млрд
Cost of goods sold
11,15 млрд
11,34 млрд
11,14 млрд
11,18 млрд
Cost of revenue
11,15 млрд
11,34 млрд
11,14 млрд
11,18 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1,03 млрд
-
-
Operating expense
5,05 млрд
5,00 млрд
5,11 млрд
5,99 млрд
Total operating expenses
16,20 млрд
16,34 млрд
16,25 млрд
17,16 млрд
Operating income
2,96 млрд
3,18 млрд
2,86 млрд
3,07 млрд
Other non operating income
-
-
-
-
EBT including unusual items
2,42 млрд
2,67 млрд
2,29 млрд
2,49 млрд
EBT excluding unusual items
2,42 млрд
2,63 млрд
2,29 млрд
2,48 млрд
Income tax expense
515,00 млн
509,00 млн
430,00 млн
564,00 млн
Effective tax rate
21,30%
19,05%
18,80%
22,61%
Other operating expenses
4,16 млрд
3,06 млрд
4,18 млрд
5,04 млрд
Net income
1,64 млрд
1,88 млрд
1,62 млрд
1,70 млрд
Net profit margin
8,57%
9,62%
8,48%
8,40%
Earnings per share
6,96
8,01
7,15
7,59
Interest and investment income
-
-
-
-
Interest expense
-561,00 млн
-572,00 млн
-584,00 млн
-599,00 млн
Net interest expenses
-561,00 млн
-572,00 млн
-584,00 млн
-599,00 млн
Depreciation and amortization charges
889,00 млн
911,00 млн
930,00 млн
944,00 млн
EBITDA
3,85 млрд
4,09 млрд
3,79 млрд
4,01 млрд
Gain or loss from assets sale
2,00 млн
-41,00 млн
1,00 млн
-10,00 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары